Archive for November, 2006

Pfizer decries counterfeit drugs risk - ABS CBN News

Pfizer decries counterfeit drugs riskABS CBN News, Philippines - 4 hours ago… Philippine International Trading Corp. (PITC) for infringement of its patent on amlodipine besylate (Norvasc). "The company decided …

Read full story

Comments

Mylan, Pfizer drug dispute a high-stakes court drama - Pittsburgh Post Gazette

Mylan, Pfizer drug dispute a high-stakes court dramaPittsburgh Post Gazette, PA - 6 hours ago… it moot. Mylan won approval to make its generic version of Norvasc — amlodipine besylate — from the FDA in October 2005. The company …

Read full story

Comments

Novartis Highlights Strong R&D Pipeline, Plans For Multiple New … - Medical News Today (press release)

Novartis Highlights Strong R&D Pipeline, Plans For Multiple New …Medical News Today (press release), UK - 3 hours ago… US regulatory decisions are also expected for Tekturna (aliskiren), a renin inhibitor for hypertension, and Exforge (valsartan and amlodipine), a single-tablet …

Read full story

Comments

Daiichi Sankyo, Inc. Announces Filing of New Drug Application for … - PR Newswire (press release)

Daiichi Sankyo, Inc. Announces Filing of New Drug Application for …PR Newswire (press release), NY - 9 hours ago… US Food and Drug Administration (FDA) for a fixed dose combination of two antihypertensives, the calcium channel blocker (CCB) amlodipine besylate (currently …

Read full story

Comments

Novartis Highlights Strong R&D Pipeline, Plans for Multiple New … - PharmaLive.com (press release)

Novartis Highlights Strong R&D Pipeline, Plans for Multiple New …PharmaLive.com (press release), PA - 9 hours ago… US regulatory decisions are also expected for Tekturna (aliskiren), a renin inhibitor for hypertension, and Exforge (valsartan and amlodipine), a single-tablet …

Read full story

Comments

MedImpact Study Compares Single- vs. Multiple-Pill Regimen … - Business Wire (press release)

MedImpact Study Compares Single- vs. Multiple-Pill Regimen …Business Wire (press release), CA - 9 hours ago… Studies compared adherence rates for one single-pill (Caduet, amlodipine + atorvastatin) combination as well as four different two-pill combinations of similar …

Read full story

Comments

Exforge® Receives Positive European Union Regulatory Opinion … - Medical News Today (press release)

Exforge® Receives Positive European Union Regulatory Opinion …Medical News Today (press release), UK - 3 hours agoNovartis announced today a positive opinion supporting European Union approval of Exforge® (valsartan/ amlodipine besylate) as a new treatment option for …

Read full story

Comments

Hypertension :: Novartis' Exforge, valsartan approved in Europe … - SpiritIndia

Hypertension :: Novartis' Exforge, valsartan approved in Europe …SpiritIndia, India - Nov 17, 2006Novartis announced today a positive opinion supporting European Union approval of Exforge® (valsartan/ amlodipine besylate) as a new treatment option for …

Read full story

Comments

Study Shows Valsartan Reduced Urinary Protein Excretion in … - DG News

Study Shows Valsartan Reduced Urinary Protein Excretion in …DG News - 2 hours ago… three groups, respectively. The most frequently prescribed add-on agents were amlodipine and hydrochlorothiazide. Despite the lower …

Read full story

Comments

Chiayi hospital raided for offering fake norvasc tablets - China Post

Chiayi hospital raided for offering fake norvasc tabletsChina Post, Taiwan - 8 hours ago… Township and a dealer of pharmaceuticals in Minhsiung township, also in Chiayi, as part of their efforts to probe the flow of fake amlodipine besylate tablets …

Read full story

Comments

· « Previous entries